Handelsblatt: Dr. Jörn-Christian Schulze comments on second Stada takeover attempt


ARQIS-Partner » Dr. Jörn-Christian Schulze « was interviewed by Handelsblatt, Germany’s leading business and finance daily. As an independent expert he analyses the entry of active hedge fund Elliott in generic drugmaker Stada which is target of a second takeover attempt by the private equity firms Bain Capital and Cinven.

You can read the full article here.